Senores Pharmaceuticals financial results announcements

Financial ResultsSenores Pharmaceuticals Ltd SENORES

Senores Pharmaceuticals Q2 FY27 Results: Net Profit ₹36.6 Cr, Up 21.6% YoY

Senores Pharmaceuticals Ltd reported revenue from operations of ₹192.3 Cr (+25.0% YoY) and net profit of ₹36.6 Cr (+21.6% YoY) for Q2 FY27.

Key figure

Net profit ₹36.6 Cr · +21.6% YoY

Financial ResultsSenores Pharmaceuticals Ltd SENORESAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Senores Pharmaceuticals Q1 FY27 Results: Net Profit ₹30.4 Cr, Up 43.4% YoY

Senores Pharmaceuticals Ltd reported revenue from operations of ₹180.2 Cr (+35.9% YoY) and net profit of ₹30.4 Cr (+43.4% YoY) for Q1 FY27.

Key figure

Net profit ₹30.4 Cr · +43.4% YoY

Financial ResultsSenores Pharmaceuticals Ltd SENORES

Senores Pharmaceuticals Q4 FY26 Results: Net Profit ₹36.7 Cr, Up 103.9% YoY

Senores Pharmaceuticals Ltd reported revenue from operations of ₹175.2 Cr (+53.4% YoY) and net profit of ₹36.7 Cr (+103.9% YoY) for Q4 FY26.

Key figure

Net profit ₹36.7 Cr · +103.9% YoY

Financial ResultsSenores Pharmaceuticals Ltd SENORES

Senores Pharmaceuticals Financial Results

Senores Pharmaceuticals reported audited FY26 consolidated total income of ₹679.89 Crore. The board also noted the resignation of the Company Secretary effective June 10, 2026.

Financial ResultsSenores Pharmaceuticals Ltd SENORES

Senores Pharmaceuticals Q3 FY26 Results: Net Profit ₹33.6 Cr, Up 104.9% YoY

Senores Pharmaceuticals Ltd reported net profit of ₹33.6 Cr (+104.9% YoY) for Q3 FY26.

Key figure

Net profit ₹33.6 Cr · +104.9% YoY